Journal of Clinical Gynecology and Obstetrics, ISSN 1927-1271 print, 1927-128X online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Gynecol Obstet and Elmer Press Inc
Journal website http://www.jcgo.org

Original Article

Volume 1, Number 2-3, June 2012, pages 40-45


Maternal Inflammatory Response in Severe Preeclamptic and Preeclamptic Pregnancies

Tables

Table 1. Demographic Properties of Groups
 
Age mean ± SDProteinuria mg/24 h mean ± SDGestational week mean ± SDParity %Early History Preeclampsia %
01≥ 2presentabsent
Normal (n = 21)27.1 ± 4.51136.0 ± 034.14 ± 4.966.716.716.70100
Preeclampsia (n = 27)29.8 ± 5.56624.8 ± 373.736.07 ± 3.471.414.314.385.214.8
Severe preeclampsia (n = 21)31.2 ± 6.564551.9 ± 3159.032.24 ± 3.060.030.010.090.59.5

 

Table 2. Factors Measurements in Preeclampsia and Severe Preeclampsia
 
IL-6 pg/mL mean ± SDIL-8 pg/mL mean ± SDIL-1β pg/mL mean ± SDTNF-α pg/mL mean ± SDCD40L ng/mL mean ± SDHSCRP mg/L mean ± SD
Values of Interleukin 6: IL-6; Interleukin 8: IL-8; Interleukin 1β: IL-1β; Tumor necrosis factor α: TNF-α; CD40 ligand: CD40L; Highly sensitive C-reactive protein: HSCRP according to the groups.
Normal (n = 21)0.95 ± 1.885.49 ± 6.452.24 ± 1.746.39 ± 3.631.27 ± 0.830.51 ± 0.26
Preeclampsia (n = 27)5.26 ± 6.1267.41 ± 124.613.06 ± 2.099.52 ± 4.271.03 ± 0.610.66 ± 0.33
Severe preeclampsia (n = 21)15.99 ± 47.82116.61 ± 246.0310.86 ± 32.5617.08 ± 27.990.99 ± 0.780.63 ± 0.29